z-logo
open-access-imgOpen Access
Synthesis, Binding and Antiviral Properties of Potent Core-Extended Naphthalene Diimides Targeting the HIV-1 Long Terminal Repeat Promoter G-Quadruplexes
Author(s) -
Rosalba Perrone,
Filippo Doria,
Elena Butovskaya,
Ilaria Frasson,
Silvia Botti,
Matteo Scalabrin,
Sara Lago,
Vincenzo Grande,
Matteo Nadai,
Mauro Freccero,
Sara N. Richter
Publication year - 2015
Publication title -
journal of medicinal chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.01
H-Index - 261
eISSN - 1520-4804
pISSN - 0022-2623
DOI - 10.1021/acs.jmedchem.5b01283
Subject(s) - chemistry , g quadruplex , selectivity , long terminal repeat , transcription (linguistics) , structure–activity relationship , stereochemistry , microbiology and biotechnology , biochemistry , dna , gene , biology , gene expression , in vitro , linguistics , philosophy , catalysis
We have previously reported that stabilization of the G-quadruplex structures in the HIV-1 long terminal repeat (LTR) promoter suppresses viral transcription. Here we sought to develop new G-quadruplex ligands to be exploited as antiviral compounds by enhancing binding toward the viral G-quadruplex structures. We synthesized naphthalene diimide derivatives with a lateral expansion of the aromatic core. The new compounds were able to bind/stabilize the G-quadruplex to a high extent, and some of them displayed clear-cut selectivity toward the viral G-quadruplexes with respect to the human telomeric G-quadruplexes. This feature translated into low nanomolar anti-HIV-1 activity toward two viral strains and encouraging selectivity indexes. The selectivity depended on specific recognition of LTR loop residues; the mechanism of action was ascribed to inhibition of LTR promoter activity in cells. This is the first example of G-quadruplex ligands that show increased selectivity toward the viral G-quadruplexes and display remarkable antiviral activity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here